Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury
This purpose of this study is to evaluate the evaluate the efficacy of Magnesium Isoglycyrrhizinate Injection in the prevention of antineoplastic chemotherapy related acute liver injury.
Neoplasms|Liver Injury
DRUG: Magnesium Isoglycyrrhizinate Injection
The incidence of liver injury, anyone of ALT、AST、ALP、TBIL、DBIL、γ-GT\>ULN, 0-15 days
Total subjects: 2040, experimental group of 1360 patients, control group of 680 patients. According to the study subjects receiving antineoplastic chemotherapy, subjects are stratified randomize.